ABCG2 and neuroblastoma: We previously reported that the pharmacological up-regulation of NDM29 by perhexiline maleate treatment drives the differentiation of NB cells, down-regulation of MDRs/ABC transporters, drug efflux proteins responsible for anticancer drug resistance, and confers an increased susceptibility to cisplatin cytotoxicity to malignant cells [19].